1. Home
  2. PCRX vs ACMR Comparison

PCRX vs ACMR Comparison

Compare PCRX & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • ACMR
  • Stock Information
  • Founded
  • PCRX 2006
  • ACMR 1998
  • Country
  • PCRX United States
  • ACMR United States
  • Employees
  • PCRX N/A
  • ACMR N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • ACMR Industrial Machinery/Components
  • Sector
  • PCRX Health Care
  • ACMR Technology
  • Exchange
  • PCRX Nasdaq
  • ACMR Nasdaq
  • Market Cap
  • PCRX 1.2B
  • ACMR 1.3B
  • IPO Year
  • PCRX 2011
  • ACMR 2017
  • Fundamental
  • Price
  • PCRX $24.10
  • ACMR $24.60
  • Analyst Decision
  • PCRX Buy
  • ACMR Buy
  • Analyst Count
  • PCRX 9
  • ACMR 5
  • Target Price
  • PCRX $29.89
  • ACMR $30.50
  • AVG Volume (30 Days)
  • PCRX 546.7K
  • ACMR 822.1K
  • Earning Date
  • PCRX 07-29-2025
  • ACMR 08-06-2025
  • Dividend Yield
  • PCRX N/A
  • ACMR N/A
  • EPS Growth
  • PCRX N/A
  • ACMR 19.75
  • EPS
  • PCRX N/A
  • ACMR 1.57
  • Revenue
  • PCRX $702,772,000.00
  • ACMR $802,274,000.00
  • Revenue This Year
  • PCRX $7.54
  • ACMR $19.19
  • Revenue Next Year
  • PCRX $10.78
  • ACMR $15.21
  • P/E Ratio
  • PCRX N/A
  • ACMR $15.54
  • Revenue Growth
  • PCRX 3.08
  • ACMR 26.21
  • 52 Week Low
  • PCRX $11.16
  • ACMR $13.87
  • 52 Week High
  • PCRX $29.61
  • ACMR $30.64
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 36.99
  • ACMR 58.56
  • Support Level
  • PCRX $23.99
  • ACMR $24.24
  • Resistance Level
  • PCRX $24.90
  • ACMR $25.77
  • Average True Range (ATR)
  • PCRX 0.88
  • ACMR 0.85
  • MACD
  • PCRX -0.21
  • ACMR 0.04
  • Stochastic Oscillator
  • PCRX 11.61
  • ACMR 64.31

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About ACMR ACM Research Inc.

ACM Research Inc supplies advanced, innovative capital equipment developed for the global semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.

Share on Social Networks: